$158 Million Settlement reached in Whistleblower case with Johnson & Johnson

Settlement Amount: 

A settlement has been reached in a whistleblower class action lawsuit brought against Johnson & Johnson who is accused of defrauding the state of Texas by misleading doctors about its antipsychotic drug Risperdal.

Johnson & Johnson's Janssen Pharmaceuticals subsidiary will pay the settlement and the whistleblower will recieve a portion of the settlement.

Filed in 2004, the originally filed whistlebower lawsuit claimed that Johnson & Johnsonhad bribed a Texas official to get Risperdal included in a preferred medication formulary operated by the state.

If you have a similar case please fill out the form below or email mail@whistleblowerinstitute.com or call: 619-452–1218


If you or someone you know experienced a similar situation or any other wrongdoing within a corporation you should contact mail@whistleblowerinstitute.com or call: 619-452–1218

Go to top